Beijing Tide Pharmaceutical Co., Ltd

This study is testing a new drug, TCC1727, combined with other cancer medications for people with advanced solid tumors that have stopped responding to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will see how w…

This is an early safety study testing a new inhaled medication called CPD704. Researchers will give single and multiple doses to 90 healthy Chinese adults to check for side effects and measure how the drug moves through the body. The main goal is to understand the drug's safety p…